Copy
See below for a daily digest of the latest Huntington's Disease news!

Genome Sequencing and Its Clinical Potential Focus of NYC Rare Disease Day Event

Mar 19, 2018 07:00 am | Larry Luxner

 

Tuuli LappalainenGenetic sequencing and the speed with which it can help diagnose a child’s disease — in addition to revealing the genes that cause at least half of the 7,000 rare diseases currently known — was the focus of a discussion by three top New York geneticists. The Feb. 28 conference, “Rare Disease Genetics: Unlocking Insights for […]

The post Genome Sequencing and Its Clinical Potential Focus of NYC Rare Disease Day Event appeared first on Huntington's Disease News.

Read More
share on Twitter Like Genome Sequencing and Its Clinical Potential Focus of NYC Rare Disease Day Event on Facebook

‘A Disease May Be Rare, Hope Should Never Be,’ Says Boy with SMARD at Connecticut Rare Disease Day Event

Mar 16, 2018 07:12 am | Larry Luxner

 

When it comes to rare diseases, one that definitely makes the list is spinal muscular atrophy with respiratory distress — SMARD,  for short. Hunter Pageau, a 12-year-old boy from North Haven, Connecticut, is one of only 80 people in the world known to have SMARD, a motor neuron disease that often kills affected children before […]

The post ‘A Disease May Be Rare, Hope Should Never Be,’ Says Boy with SMARD at Connecticut Rare Disease Day Event appeared first on Huntington's Disease News.

Read More
share on Twitter Like ‘A Disease May Be Rare, Hope Should Never Be,’ Says Boy with SMARD at Connecticut Rare Disease Day Event on Facebook

MMJ BioScience Licensed in Canada to Make Cannabis-based Medicine for Huntington’s Studies

Mar 15, 2018 09:00 am | Carolina Henriques

 

MMJ BioScienceMMJ BioScience received a licence from Health Canada to develop cannabis-derived products based on proprietary formulations for the treatment of Huntington’s disease and multiple sclerosis (MS). The license will enable MMJ to extract active pharmaceutical ingredients from the cannabis plant to manufacture gelcap medications and supply pharmaceutical-grade medicines for its studies which have been approved by […]

The post MMJ BioScience Licensed in Canada to Make Cannabis-based Medicine for Huntington’s Studies appeared first on Huntington's Disease News.

Read More
share on Twitter Like MMJ BioScience Licensed in Canada to Make Cannabis-based Medicine for Huntington’s Studies on Facebook

Recent Posts

Rare Disease Groups Welcome FDA’s Embrace of ‘Real World’ Data in Clinical Trials
US Lawmakers Urge Bipartisan Support for Rare Disease Research, Patients’ Needs
IONIS-HTTRx Shows Promising Results in Phase 1/2 Clinical Trial
HDSA Expands List of Huntington’s Disease Centers of Excellence to 43 for 2018
Blocking Certain Glutamate Receptors Seen to Ease Huntington’s Advance in Mouse Model of Disease

Copyright © 2018 BioNews Services, LLC, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences